Evidence on outcomes studied for Liraglutide
Evidence related to liraglutide and liraglutide-containing intervention regimens in diabetes studies.
Among 10 indexed studies and 3 interventions, the strongest signals are summarized from deterministic graph patterns. Body weight has been studied often, while HbA1c appears to have stronger current evidence signals.
Dediabetes summarizes indexed research evidence for education and discovery. This content is not medical advice and should not replace guidance from a qualified clinician.
Research documents analyzed
Intervention-outcome relationships
Qualitative overview of the evidence landscape
Based on 10 studies, emerging evidence suggests HbA1c, Body weight, Incidence of vascular events within 90 days are the strongest-supported outcomes for liraglutide.
A structured summary of where the evidence is strongest, mixed, or still emerging.
Among 10 indexed studies and 3 interventions, the strongest signals are summarized from deterministic graph patterns. Body weight has been studied often, while HbA1c appears to have stronger current evidence signals.
This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.
Latest indexed evidence: May 2026
Interventions with strongest consistent evidence
The current evidence does not yet show a clear consistent-benefit pattern.
Areas where results are mixed
Mixed results suggest effects may depend on population, comparator, duration, or study design.
All-cause mortality is mixed in the currently indexed evidence.
Some supporting studies reported neutral, negative, or mixed findings.
Promising areas needing more evidence
Promising signals can guide further review, but they should not be treated as settled evidence.
HbA1c may have a beneficial signal, but the evidence base is still developing.
Current support is limited by study volume, RCT depth, or evidence strength.
Organized using the Dediabetes Evidence Intelligence™ framework.
HbA1c, Body weight, and BMI are among the most studied areas in relation to Liraglutide.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
HbA1c
EvidenceScore™ Moderate | EvidenceScore™ 60.6 | strong positive | ConsensusScore™ Consistent | 2 studies
Body weight
EvidenceScore™ Emerging | EvidenceScore™ 52.2 | moderate positive | ConsensusScore™ Consistent | 4 studies
Ischemic stroke
EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on 10 supporting studies and existing graph evidence signals.
Limitations
Liraglutide appears to improve HbA1c.
ConsensusScore™: Results are consistent across studies.
Ranked evidence signals
HbA1c
EvidenceScore™ Moderate | EvidenceScore™ 60.6 | strong positive | ConsensusScore™ Consistent | 2 studies
Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.
Limitations
Liraglutide may improve Body weight.
ConsensusScore™: Results are consistent across studies.
Ranked evidence signals
Body weight
EvidenceScore™ Emerging | EvidenceScore™ 52.2 | moderate positive | ConsensusScore™ Consistent | 4 studies
Why this answer: This answer is based on 4 supporting studies with consistent results and a positive effect signal.
Limitations
HbA1c, Body weight, and BMI have the strongest available evidence signals for Liraglutide.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
HbA1c
EvidenceScore™ Moderate | EvidenceScore™ 60.6 | strong positive | ConsensusScore™ Consistent | 2 studies
Body weight
EvidenceScore™ Emerging | EvidenceScore™ 52.2 | moderate positive | ConsensusScore™ Consistent | 4 studies
BMI
EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on 4 supporting studies and existing graph evidence signals.
Limitations
HbA1c, BMI, and Body fat mass need more research in relation to Liraglutide.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
HbA1c
EvidenceScore™ Moderate | EvidenceScore™ 60.6 | strong positive | ConsensusScore™ Consistent | 2 studies
BMI
EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study
Body fat mass
EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on 3 supporting studies and existing graph evidence signals.
Limitations
HbA1c, Body weight, and BMI have available evidence for Liraglutide, but the comparison requires review of the underlying studies.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
HbA1c
EvidenceScore™ Moderate | EvidenceScore™ 60.6 | strong positive | ConsensusScore™ Consistent | 2 studies
Body weight
EvidenceScore™ Emerging | EvidenceScore™ 52.2 | moderate positive | ConsensusScore™ Consistent | 4 studies
BMI
EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on 4 supporting studies and existing graph evidence signals.
Limitations
Outcome areas reported in the evidence summary.
Key patterns and insights identified across the research landscape
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
Across 2 studies, Liraglutide shows a consistent strong positive signal for HbA1c.
Across 3 studies, Liraglutide shows a consistent moderate positive signal for Body weight.
Across 1 study, Liraglutide shows a strong positive signal for Ischemic stroke.
Across 1 study, Liraglutide shows a strong positive signal for Modified Rankin Scale score ≤ 1.
Across 1 study, Liraglutide shows a strong positive signal for Olfactory task functional connectivity.
Studies connected to this intervention in the evidence record.
Click outcomes and interventions to filter the archive when links are available.
Browse the complete evidence archive for this topic, including interventions, outcomes, and related research.
Explore all Liraglutide evidenceFilter by study type, publication date, effect size, and more to refine your research
